Can systemic immune-inflammation index and hematologic parameters aid in decision-making for active surveillance or curative treatment in low-risk prostate cancer?

Can systemic immune-inflammation index and hematologic parameters aid in decision-making for active surveillance or curative treatment in low-risk prostate cancer?

Introduction: Pathologic Gleason Score (GS) upgrading is common in patients with low-risk localized prostate cancer (PCa) who are followed by active surveillance (AS) or undergo radical prostatectomy (RP). This fact raises concerns about inadequate treatment, especially in AS patients. We aimed to a...

Full description

Bibliographic Details
Main Authors: Burhan Baylan, Kemal Ulusoy, Berk Ekenci, Ibrahim Guven Kartal
Format: Article
Language:English
Published: Elsevier 2024-03-01
Series:Asian Journal of Surgery
Subjects:
Prostate cancer
Active surveillance
NLR
PLR
SII index
Online Access:http://www.sciencedirect.com/science/article/pii/S101595842301922X

Internet

http://www.sciencedirect.com/science/article/pii/S101595842301922X

Similar Items